Switzerland
Industry
Biotechnology firm Cytos is to link up with US pharmaceutical giant Pfizer in the development of vaccines for a number of human diseases, the Swiss firm announced on August 15 2008....
2008-08-21Industry
Strong growth in Central and Eastern Europe (CEE) for Sandoz, Novartis' generics division, has made a significant contribution to the generics company's H108 results. In US dollar...
2008-07-24Industry
Swiss biopharmaceuticals firm Actelion has secured a lucrative licensing deal with GlaxoSmithKline (GSK) for its insomnia candidate almorexant. In return for worldwide marketing rights...
2008-07-15Companies
Swiss firm Novartis has purchased 74mn shares of Alcon Laboratories from its parent company Nestle.
2008-07-11Companies
Swiss drugmaker Novartis looks set to take over fellow domestic player and long-standing research partner Speedel in a deal worth a potential US$880mn. On July 10 2008 Novartis, which...
2008-07-11Industry
Following a negative appraisal from the UK's National Institute for Health and Clinical Excellence (NICE), Roche is to lower the price of its non-small cell lung cancer treatment...
2008-07-09Industry
In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed...
2008-06-24Industry
The Swiss biotech sector attracted record levels of investment and healthy market growth during 2007, according Swiss Biotech's 2008 annual report. However, while company revenues...
2008-06-20
